Abstract
Diisopropylfluorophosphate (DFP), a potent and irreversible esterate inhibitor, was first suggested as a red cell label by Grob, Lilienthal, Harvey, and Jones in 1947 [1]. In 1954 Cohen and Warringa [2] described the use of DFP containing radioactive phosphorous (DFP-P32) as a label for erythrocytes, and two years later Leeksma and Cohen [3] described the use of DFP-P32 as a platelet label. The latter authors found relatively little label in leukocytes.
Presented at the Sixth Symposium on Advances in Tracer Methodology, November, 1962.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grob, D., Lilienthal. J. L., Jr., Harvey, A.M., and Jones, B. F., Bull. Johns Hopkins Hosp. 81:217 (1947).
Cohen, J.A., and Warringa, M.G. P. J., J. Clin. Invest, 33: 459 (1954).
Leeksma, C. H. W., and Cohen, J.A., J. Clin. Invest. 35: 964 (1956).
Athens, J. W., Mauer, A. M., Ashenbrucker, H., Cartwright, G. E., and Wintrobe, M. M., Blood 14: 303 (1959).
Mauer, A. M., Athens, J. W., Ashenbrucker, H., Cartwright, G. E., and Wintrobe, M. M., J. Clin. Invest. 39: 1481 (1960).
Kurth, D., Athens, J. W., Cronkite, E. P., Cartwright, G. E., and Wintrobe, M. M., Proc. Soc. Exp. Biol. Med. 107: 422 (1961).
Athens, J. W., Raab, S. O., Haab, O. P., Mauer, A.M., Ashenbrucker, H., Cartwright, G. E., and Wintrobe, M. M., J. Clin. Invest. 40: 159 (1961).
Vejlens, G., Acta Pathol. Microbiol. Scand. Suppl. 33 (1938).
Athens, J. W., Haab, O. P., Raab, S. O., Mauer, A. M., Ashenbrucker, H., Cartwright, G.E., and Wintrobe, M.M., J. Clin. Invest. 40: 989 (1961).
Oosterbaan, R. A., Jausz, H. S., and Cohen, J.A., Biochem. Biophys. Acta 20: 402 (1956).
Schaffer, N. K., Simet, L., Harshman, S., Engle, R. R., and Drisko, R. W., J. Biol. Chem. 225: 197 (1957).
Mazur, A., and Bodansky, O., J. Biol. Chem. 163: 261 (1946).
Jandorf, B. J., and McNamara, P.D., J. Pharmacol. Exp. Therap. 98: 77 (1950).
Eadie, G. S., Smith, W. W., and Brown, I. W., Jr., J. Gen. Physiol. 43: 825 (1960).
Hjort, P. F., Paputchis, H., and Cheney, B., J. Lab. Clin. Med. 55: 416 (1960).
Mayer, K., and Ley, A. B., Clin. Res. Proc. 4: 80 (1956).
Bove, J.R., and Ebaugh, F.G., Jr., J. Lab. Clin. Med. 51: 916 (1958).
Pollycove, M., Dal Santo, G., and Lawrence, J. H., Clin. Res. Proc. 6: 45 (1958).
Eernisse, J.G., and van Rood, J. J., Brit. J. Haematol. 7: 382 (1961).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1965 New England Nuclear Corporation
About this chapter
Cite this chapter
Raab, S.O. (1965). Diisopropylfluorophosphate-P32 (DFP-P32) as a Label for Granulocytes. In: Rothchild, S. (eds) Advances in Tracer Methodology. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-8622-3_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8622-3_30
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-8624-7
Online ISBN: 978-1-4684-8622-3
eBook Packages: Springer Book Archive